We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBC icon
1776
MasterBrand
MBC
$1.15B
$1.72M ﹤0.01%
+228,071
New +$1.87M
EGHT icon
1777
8x8 Inc
EGHT
$271M
$1.72M ﹤0.01%
+397,747
New +$1.6M
GBBK
1778
DELISTED
Global Blockchain Acquisition Corp. Common Stock
GBBK
$1.72M ﹤0.01%
169,674
MNRO icon
1779
Monro
MNRO
$537M
$1.71M ﹤0.01%
+37,811
New +$1.75M
DTI icon
1780
Drilling Tools International
DTI
$79.4M
$1.71M ﹤0.01%
166,751
ONYXW
1781
CALL
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$1.7M ﹤0.01%
164,999
ARCKW
1782
CALL
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Warrants
ARCKW
$1.7M ﹤0.01%
150,519
SABR icon
1783
Sabre
SABR
$743M
$1.7M ﹤0.01%
274,312
+33,548
+14% +$187K
GNE icon
1784
Genie Energy
GNE
$378M
$1.69M ﹤0.01%
163,609
+107,900
+194% +$1.05M
CORS.WS
1785
CALL
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$1.69M ﹤0.01%
166,663
BECN
1786
DELISTED
Beacon Roofing Supply, Inc.
BECN
$1.69M ﹤0.01%
+31,958
New +$1.81M
CNDA.WS
1787
CALL
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$1.68M ﹤0.01%
169,344
POWRW
1788
CALL
DELISTED
Powered Brands Warrants
POWRW
$1.68M ﹤0.01%
166,660
FG icon
1789
F&G Annuities & Life
FG
$4.03B
$1.68M ﹤0.01%
+84,159
New +$1.72M
NRACW
1790
CALL
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$1.68M ﹤0.01%
166,632
FINMW
1791
CALL
DELISTED
Marlin Technology Corporation Warrant
FINMW
$1.68M ﹤0.01%
165,776
CMPR icon
1792
Cimpress
CMPR
$2.43B
$1.68M ﹤0.01%
+60,763
New +$1.58M
CPAAW
1793
CALL
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$1.67M ﹤0.01%
166,662
LX
1794
LexinFintech Holdings
LX
$241M
$1.67M ﹤0.01%
880,139
-349,659
-28% -$584K
LXU icon
1795
LSB Industries
LXU
$822M
$1.67M ﹤0.01%
125,662
-1,394,893
-92% -$20.8M
MIST icon
1796
Milestone Pharmaceuticals
MIST
$133M
$1.67M ﹤0.01%
421,540
+390,642
+1,264% +$2.06M
NXRT
1797
NexPoint Residential Trust
NXRT
$686M
$1.67M ﹤0.01%
38,331
-19,812
-34% -$886K
FICV
1798
DELISTED
Frontier Investment Corp Class A Ordinary Shares
FICV
$1.67M ﹤0.01%
165,708
KLRS
1799
Kalaris Therapeutics
KLRS
$79.5M
$1.67M ﹤0.01%
14,116
TTC icon
1800
Toro Company
TTC
$9.08B
$1.67M ﹤0.01%
+14,709
New +$1.56M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.